Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

UnitedHealth gets FTC approval for DaVita unit purchase

UnitedHealth Group Inc. won anti-trust approval to buy DaVita Inc.’s primary and urgent care unit for $4.3 billion, the Federal Trade Commission said.

Read More »

Catalent to Buy Bristol-Myers’ Factory in Italy

Contract research organization Catalent plans to buy Bristol-Myers Squibb’s manufacturing and packaging factory in Anagni, Italy, used to manufacture oral solid, biologics and sterile products.

Read More »

Comet Therapeutics Earns $28.5 Million Series A with Sight Set on Metabolic Diseases

With $28.5 million in financing, Cambridge, Mass.-based Comet Therapeutics is emerging from stealth mode with a focus on developing a portfolio of drug candidates that centers around efforts to re-engineer CoEnzyme-A (CoA).

Read More »

Merck to Showcase Oncology Pipeline at Investor Day Amid Concerns About Dependence on Keytruda

With two new approvals for the vaunted checkpoint inhibitor Keytruda and a rapidly expanding oncology pipeline following M&A deals, Merck & Co. plans to share outlines for the future of the company’s cancer treatment at the first investor day held in five years.

Read More »

Sanofi plans 466 job cuts as part of R&D reshuffle

Sanofi said a reorganization of the company’s research and development operation in Germany and France would result in 466 job cuts in the two countries.

Read More »

Gilead and Nurix Establish Strategic Collaboration

Gilead Sciences Inc. and Nurix Therapeutics Inc. announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted protein degradation drugs for patients with cancer and other challenging diseases.

Read More »

FDA Action Alert: Merck, Agios and AMAG Pharma

June 2019 is a busy month for approval applications for the U.S. Food and Drug Administration as the regulatory agency has a slate of PDUFA dates.

Read More »

Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes

Abbott’s Afinion HbA1c Dx assay was launched as the only rapid point-of-care test cleared by the U.S. Food and Drug Administration to aid healthcare professionals in the diagnosis of diabetes and the assessment of patients’ risk of developing the condition.

Read More »

Pfizer bolsters cancer portfolio with Array deal

Pfizer Inc. struck a deal with an enterprise value of about $11.4 billion to buy Array BioPharma Inc. to expand the company’s portfolio of potentially lucrative cancer drugs.

Read More »

U.S. drugmakers file lawsuit over TV ad drug pricing

U.S. drugmakers filed a lawsuit challenging a new government regulation that would require them to disclose the list price of prescription drugs in direct-to-consumer television advertisements.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom